Ambev S.A.
NYSE:ABEVBeverages - Alcoholic
-$0.02 today
- Market cap
- $42.89B
- Beta
- 0.27
- P/E (TTM)
- 16.2
- EPS (TTM)
- $1.00
- Dividend yield
- 9.76%
Volume 11.24M
Average 27.73M
ABEV Other Financing Activities
Financing cash flows not reported separately.
Ambev S.A.NYSE: ABEV
Other Financing Activities · Q2 FY2026 · quarter ended Jun 2026
Other financing activities growth accelerates
Q2 FY2026 other financing activities of R$1.02B (cash outflow) rose 25.5% year over year, ahead of the -8.6% change in trailing-twelve-month other financing activities. Sequentially, it rose 108.7% from the prior quarter. Over 3 fiscal years it compounded at -1.6% a year.
Context
- Other financing activities amounted to 3.5% of revenue in FY2025, down 1.4 pp from a year earlier.
- Other financing activities grew in size in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +25.5% holds above the trailing-twelve-month pace of -8.6%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Financing Activities history
BRL · from the cash flow
- Latest · FY2025
- (3.1B) BRL
- Year-over-year change
- +29.5%
| Period | Period end | Other Financing Activities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (3.1B) | +29.5% |
| FY2024 | 2024-12-31 | (4.4B) | -61.1% |
| FY2023 | 2023-12-31 | (2.73B) | +16.1% |
| FY2022 | 2022-12-31 | (3.26B) | -55.8% |
| FY2021 | 2021-12-31 | (2.09B) | — |
Other Financing Activities vs competitors
How ABEV compares with its peers on the latest reported figures
- Peers report in different currencies, so other financing activities is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -8.6% is the 3rd highest of 5, against a peer median of -20.7%.
- Other financing activities amounts to 3.4% of revenue for ABEV, versus a peer median of 2.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | CLP 59.2B CLP | -46.5% | +174.7% | 2.0% | |
| LTM Jun 2026 | R$2.96B BRL | -8.6% | -1.6% | 3.4% | |
| FY2025 | $1.83B USD | -7.5% | +44.1% | 3.1% | |
| LTM Jun 2026 | $1.55B USD | — | -57.1% | 3.2% | |
| LTM Aug 2026 | $117.3M USD | +68.3% | +7.2% | 1.3% | |
| LTM Jun 2026 | $63.2M USD | -33.9% | +89.7% | 0.6% | |
| Peer median (excluding ABEV) | — | -20.7% | +44.1% | 2.0% | |
Competitors are the stored peer set for ABEV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 13.12B | 14.89B | 14.96B | 14.85B | 15.99B |
| Depreciation & Amortization | 5.4B | 5.96B | 6.42B | 7.13B | 6.83B |
| Deferred Income Tax | 853.2M | (316M) | 253.8M | 4.91B | 3.7B |
| Stock-Based Compensation | 387.6M | 313.9M | 331.6M | 400.9M | 454.2M |
| Change in Working Capital | 3B | (2.68B) | (296.1M) | (165M) | (1.62B) |
| Accounts Receivables | 341.4M | (322.5M) | (1.37B) | 220.4M | (312.9M) |
| Inventory | (3.5B) | (3.09B) | 1.3B | (1.7B) | (30.9M) |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | 6.16B | 726.6M | (223.1M) | 1.32B | (1.27B) |
| Other Non-Cash Items | 141.8M | 2.48B | 3.04B | (1.03B) | (908.2M) |
| Operating Cash Flow | 22.9B | 20.64B | 24.71B | 26.1B | 24.45B |
| Capital Expenditures | (7.68B) | (6.53B) | (6B) | (4.75B) | (4.59B) |
| Acquisitions (Net) | (133.3M) | (33M) | (52.8M) | 10.3M | (91.6M) |
| Purchases of Investments | (241.3M) | (30M) | (6.3M) | (888.6M) | (441.5M) |
| Sales of Investments | 0 | 1.41B | 136.4M | 0 | 0 |
| Other Investing Activities | 316.7M | 178.9M | 160.8M | 164M | 173.5M |
| Investing Cash Flow | (7.74B) | (5B) | (5.77B) | (5.46B) | (4.95B) |
| Debt Repayment | (2.8B) | (810M) | (1.36B) | (1.45B) | (1.28B) |
| Common Stock Issued | 9.1M | 23.8M | 14.5M | 17.5M | 0 |
| Common Stock Repurchased | (44.2M) | (54.1M) | (119M) | (467.6M) | (1.93B) |
| Dividends Paid | (11.12B) | (12.24B) | (11.92B) | (4.06B) | (20.46B) |
| Other Financing Activities | (2.09B) | (3.26B) | (2.73B) | (4.4B) | (3.1B) |
| Financing Cash Flow | (16.04B) | (16.34B) | (16.12B) | (10.35B) | (26.77B) |
| Effect of Forex Changes | 382.6M | (1.05B) | (1.62B) | 2.25B | (2.69B) |
| Net Change in Cash | (493.1M) | (1.75B) | 1.21B | 12.54B | (9.96B) |
| Free Cash Flow | 15.22B | 14.11B | 18.71B | 21.35B | 19.86B |
Ambev S.A.
NYSE:ABEV
Intrinsic Alpha fair value
Locked
Current Price
$2.70
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.